Standard

Harvard

APA

Vancouver

Author

BibTeX

@article{f7ae569a87264534b364b0b51cae6b67,
title = "Return to Work of Patients Treated With Spinal Cord Stimulation for Chronic Pain: A Systematic Review and Meta-Analysis",
abstract = "BACKGROUND: Chronic pain has a substantial negative impact on work-related outcomes, which underscores the importance of interventions to reduce the burden. Spinal cord stimulation (SCS) efficiently causes pain relief in specific chronic pain syndromes. The aim of this review was to identify and summarize evidence on returning to work in patients with chronic pain treated with SCS.MATERIALS AND METHODS: A systematic literature review was performed including studies from PubMed, EMBASE, SCOPUS, and Web of Science (up till October 2017). Risk of bias was assessed using a modified version of the Downs & Black checklist. Where possible, we pooled data using random effects meta-analysis. The study protocol was registered prior to initiation of the review process (PROSPERO CRD42017077803).RESULTS: Fifteen full-text articles (total articles screened: 2835) were included. Risk of bias for these articles was scored low. Seven trials provided sufficient data and were judged similar enough to be pooled for meta-analysis on binary outcomes. SCS intervention results in a higher prevalence of patients at work compared with before treatment (odds ratio [OR] 2.15; 95{\%} confidence interval [CI], 1.44-3.21; I2  = 42{\%}; p < 0.001). SCS treatment also results in high odds to return to work (OR 29.06; 95{\%} CI, 9.73-86.75; I2  = 0{\%}; p < 0.001).CONCLUSIONS: Based on available literature, SCS proved to be an effective approach to stimulate return to work in patients with specific chronic pain syndromes.",
keywords = "Chronic Pain/diagnosis, Humans, Pain Management/methods, Pain Measurement/methods, Prospective Studies, Randomized Controlled Trials as Topic/methods, Retrospective Studies, Return to Work/trends, Spinal Cord Stimulation/methods",
author = "Maarten Moens and Lisa Goudman and Raf Brouns and {Valenzuela Espinoza}, Alexis and {De Jaeger}, Mats and Eva Huysmans and Koen Putman and Jan Verlooy",
note = "{\circledC} 2018 International Neuromodulation Society.",
year = "2019",
month = "4",
doi = "10.1111/ner.12797",
language = "English",
volume = "22",
pages = "253--261",
journal = "Neuromodulation",
issn = "1094-7159",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Return to Work of Patients Treated With Spinal Cord Stimulation for Chronic Pain

T2 - A Systematic Review and Meta-Analysis

AU - Moens, Maarten

AU - Goudman, Lisa

AU - Brouns, Raf

AU - Valenzuela Espinoza, Alexis

AU - De Jaeger, Mats

AU - Huysmans, Eva

AU - Putman, Koen

AU - Verlooy, Jan

N1 - © 2018 International Neuromodulation Society.

PY - 2019/4

Y1 - 2019/4

N2 - BACKGROUND: Chronic pain has a substantial negative impact on work-related outcomes, which underscores the importance of interventions to reduce the burden. Spinal cord stimulation (SCS) efficiently causes pain relief in specific chronic pain syndromes. The aim of this review was to identify and summarize evidence on returning to work in patients with chronic pain treated with SCS.MATERIALS AND METHODS: A systematic literature review was performed including studies from PubMed, EMBASE, SCOPUS, and Web of Science (up till October 2017). Risk of bias was assessed using a modified version of the Downs & Black checklist. Where possible, we pooled data using random effects meta-analysis. The study protocol was registered prior to initiation of the review process (PROSPERO CRD42017077803).RESULTS: Fifteen full-text articles (total articles screened: 2835) were included. Risk of bias for these articles was scored low. Seven trials provided sufficient data and were judged similar enough to be pooled for meta-analysis on binary outcomes. SCS intervention results in a higher prevalence of patients at work compared with before treatment (odds ratio [OR] 2.15; 95% confidence interval [CI], 1.44-3.21; I2  = 42%; p < 0.001). SCS treatment also results in high odds to return to work (OR 29.06; 95% CI, 9.73-86.75; I2  = 0%; p < 0.001).CONCLUSIONS: Based on available literature, SCS proved to be an effective approach to stimulate return to work in patients with specific chronic pain syndromes.

AB - BACKGROUND: Chronic pain has a substantial negative impact on work-related outcomes, which underscores the importance of interventions to reduce the burden. Spinal cord stimulation (SCS) efficiently causes pain relief in specific chronic pain syndromes. The aim of this review was to identify and summarize evidence on returning to work in patients with chronic pain treated with SCS.MATERIALS AND METHODS: A systematic literature review was performed including studies from PubMed, EMBASE, SCOPUS, and Web of Science (up till October 2017). Risk of bias was assessed using a modified version of the Downs & Black checklist. Where possible, we pooled data using random effects meta-analysis. The study protocol was registered prior to initiation of the review process (PROSPERO CRD42017077803).RESULTS: Fifteen full-text articles (total articles screened: 2835) were included. Risk of bias for these articles was scored low. Seven trials provided sufficient data and were judged similar enough to be pooled for meta-analysis on binary outcomes. SCS intervention results in a higher prevalence of patients at work compared with before treatment (odds ratio [OR] 2.15; 95% confidence interval [CI], 1.44-3.21; I2  = 42%; p < 0.001). SCS treatment also results in high odds to return to work (OR 29.06; 95% CI, 9.73-86.75; I2  = 0%; p < 0.001).CONCLUSIONS: Based on available literature, SCS proved to be an effective approach to stimulate return to work in patients with specific chronic pain syndromes.

KW - Chronic Pain/diagnosis

KW - Humans

KW - Pain Management/methods

KW - Pain Measurement/methods

KW - Prospective Studies

KW - Randomized Controlled Trials as Topic/methods

KW - Retrospective Studies

KW - Return to Work/trends

KW - Spinal Cord Stimulation/methods

UR - http://www.scopus.com/inward/record.url?scp=85052473696&partnerID=8YFLogxK

U2 - 10.1111/ner.12797

DO - 10.1111/ner.12797

M3 - Article

C2 - 30117650

VL - 22

SP - 253

EP - 261

JO - Neuromodulation

JF - Neuromodulation

SN - 1094-7159

IS - 3

ER -

ID: 39828057